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Nephropathy of type II diabetes: Evidence for hereditary factors?
Family studies point to an important genetic element in the genesis of
diabetic nephropathy, but it is not known whether renal abnormalities are
present prior to the onset of diabetes. To address this issue we examined
all consecutive patients suffering from type II diabetes with a duration of
more than 10 years who attended a diabetes outpatient clinic. Ninety-four
patients had nephropathy, 307 did not. All offspring who were phenotyp-
ically normal (no hypertension, normal oral glucose tolerance, non-
smoking) and agreed to participate were examined, 26 from nephropathic
and 30 from non-nephropathic diabetic parents. They were compared with
30 offspring matched for age, gender and BMI from non-diabetic parents
as controls. We measured urinary albumin excretion under baseline
conditions and at several time points after ingestion of 300 g cooked beef
and submaximal treadmill exercise, respectively. In addition, casual blood
pressure, ambulatory blood pressure, urinary albumin and urinary alpha-
1-microglobulin were measured. Primary renal disease was excluded by
clinical examination. Under baseline conditions, median urinary albumin
excretion rate (AER; jsglmin) was significantly (P < 0.005) higher in
offspring of nephropathic type II diabetic patients (7.8; range 1.04 to 19.5)
than in the offspring of non-nephropathic type II diabetic patients (4.8;
0.36 to 17.5) and controls (4.4; 0.16 to 18.4). Submaximal treadmill
exercise caused a greater proportional increase of AER in offspring of
nephropathic type II diabetics (median 16-fold) than in offspring of
non-nephropathic diabetic patients (6.3-fold) or controls (4.8-fold). In
offspring of nephropathic diabetic patients casual and particularly ambu-
latory systolic blood pressures were significantly higher, but AER was not
correlated with blood pressure. In summary, higher values, albeit within
the normal range, for baseline and postexercise albuminuria were noted in
phenotypically normal offspring of parents with type II diabetes and
nephropathy. The observation suggests that changes in transglomerular
albumin traffic are demonstrable prior to the onset of diabetes and
diabetic nephropathy in subjects with a potential genetic predisposition to
these conditions.
There is convincing evidence for a genetic basis of type II
diabetes [1]. Diabetic nephropathy is observed in up to 30% of
patients who suffer from type II diabetes for more than 10 years
[2, 3]. Familial aggregation of nephropathy in type II dialjetcs has
been noted both in Pima Indians [4] and Caucasoids [5]. This
observation is consistent with, but not definite evidence for the
hypothesis that independent genes code for type II diabetes on
the one hand and development of diabetic nephropathy on the
other hand.
Phenotypically normal offspring of parents with type II diabetes
Received for publication July 22, 1996
and in revised form October 21, 1996
Accepted for publication December 9, 1996
© 1997 by the International Society of Nephrology
have marked abnormalities of insulin and glucose metabolism
even when they are still normotensive and exhibit no glucose
intolerance [6, 7].
Little is known, however, concerning potential early abnormal-
ities of albumin excretion in offspring of parents with type II
diabetes and diabetic nephropathy. In one study [8], higher
urinary albumin excretion rates were noted in the offspring of
diabetic patients with type II diabetes, but detailed investigations
of the response of albuminuria to interventions were not per-
formed in this cohort for which subjects had not been randomly
selected.
To further address this issue, we examined a large cohort of
adult subjects with type II diabetes of long duration both with and
without nephropathy, excluding MODY and patients suggestive
of mitochondrial diabetes. Presence of nephropathy was diag-
nosed on the basis of elevated urinary albumin excretion.
In a second step we examined all available offspring measuring
(i) blood pressure and (ii) urinary albumin excretion under
baseline conditions and under stimulatory maneuvers.
Methods
Description of study cohorts
All consecutive type II diabetic patients who visited the outpa-
tient clinic in Zabrze (Poland) either de novo or for routine
controls between November 1994 and June 1995 were identified.
Type II diabetes was diagnosed according to the criteria of the
National Diabetes Data Group (NDDG) [9]. Only patients with
known duration of type II diabetes for more than 10 years were
considered for further workup (that is, diabetes of sufficient
duration to allow development of nephropathy). Standard chronic
primary renal disease was excluded by urine analysis (phase
contrast microscopy, bacterial culture), renal ultrasonography and
clinical workup. Of the 425 patients, 24 were excluded because of
primary chronic renal disease. Diabetic riephropathy, that is, > 30
mg albumin/24 hr on at least two of three occasions with or
without elevated serum creatinine was present in 94 and absent in
307 patients. Of the former, 14 had no children and in 33 children
were not locally available for study. The respective numbers for
the latter group were 26 and 163. Exclusion criteria for the
offspring were hypertension, that is, > 140/90 mm Hg under
resting conditions, and glucose intolerance, that is, > 140 mg/dl
two hours after 75 g oral glucose. Furthermore, smokers and
patients on oral contraceptives were excluded. After exclusion of
offspring who refused cooperation (N = 86) or who met exclusion
criteria (N = 23) the study concerned the families of 56 parents
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Offspring of parents with
Diabetes
Diabetes plus No
no diabetic diabetic diabetes
nephropathy ncphropathy (controls)(N = 30) (N= 26) (N = 30)
Age years 33.0 8.5 33.0 6.5 31.5 5.4
Gender male/female 15/15 14/12 15/15
BMI kg/rn2 26.2 5.1 26.6 3.4 25.5 3.0
BMI > 25 7 (7) 16 (4) 15 (2)
(>30 kg/rn2)
HbAlc % 4.85 0.46 5.23 0.33 4.90 0.38
MAP mm Hg 87 8.6 90 10.2 85 0.00
Total cholesterol 4.87 1.14 4.88 1.16 4.41 0.91
mmol/liter
Triglycerides 1.01 0.65 1.06 0.59 0.91 0.32
rnrnol/liter
Urine urea nitrogen 340 50 330 47 321 37
mrnol/day
Na excretion 150 24 145 23 148 19.2
mmol/24 hr
(median 59 years, range 51 to 76; 19 fathers, 37 mothers) who had
type II diabetes of more than 10 years duration and whose
children were locally available for the study. Diabetic nephropathy
was present in 26 of the parents (11 fathers, 15 mothers) and
absent in 30 (8 fathers, 22 mothers). Established hypertension,
that is, blood pressure > 160/95 mm Hg or antihypertensive
treatment, was present in 21 of 26 nephropathic and 14 of 30
non-nephropathic parents.
Study subjects (offspring of diabetic and non-diabetic parents)
We examined 56 offspring of the above diabetic patients. The
relevant demographic and clinical data are summarized in Table 1.
Among the offspring of diabetic parents without nephropathy,
diabetes was present on the father's side in 8 and on the mothers's
side in 22. The respective numbers for offspring of diabetic
parents with nephropathy were 11 on the father's side and 15 on
the mother's side. None of the offspring of diabetic mothers had
evidence of mitochondriopathy.
In the subsequent analyses no significant difference was noted
according to whether diabetes was present in the father or the
mother.
Despite considerable effort no information could be obtained
on birth weight of the propositi.
As controls we examined 30 local offspring of non-diabetic
parents without history of hypertension. The controls were re-
cruited from the staff of the diabetes clinic and matched for age,
gender and body mass index.
Study protocol
All subjects collected overnight urine for analysis of albumin,
alpha-1-microglobulin and creatinine. They were seen in the
outpatient clinic at 9 a.m. and passed urine. They stayed in a quiet
room in supine position except for passing urine. At 9 a.m. they
had an oral water load (10 mI/kg); urine was collected and BP was
measured at 15 minute intervals. At 10 hours they ingested 300 g
cooked beef and urine collections and BP measurements were
continued for three hours.
Patients were asked to drink an amount of water that corre-
sponded to the volume of urine passed.
Fig. 1. Night time albumin excretion rate (AER) in offspring of control
parents and diabetic parents without and with diabetic nephropathy (DN).
Significant difference between offspring of parents with DN and without
DN (x P < 0.05) or DN and controls (xx P < 0.005).
On a second day, the individuals were subjected to a submaxi-
mal treadmill exercise test at 80% of target heart rate. Urine was
collected immediately after exercise, one hour after exercise and
subsequently after night time rest.
Ambulatory blood pressure was measured on a work day
several weeks after the study under outpatient conditions using a
Medilog ABP (Oxford, UK). Patients wrote a protocol to docu-
ment their activities and time of bed rest.
Measurements
Urinary albumin by was measured by radioimmunoassay [101.
Urinary alpha-1-microglobulin was measured by laser nephelom-
etry [111, urinary creatinine by spectrophotometry, hemoglobin
A1C by immunoagglutination inhibition using a DCA-2000 auto-
analyzer (Bayer Diagnostics, Elkhard, IN, USA), polymorphisms
of the genes of the renin angiotensin system (ACE, angiotensino-
gen, AT1 receptor) according to [12—14].
Statistics
End points were defined prior to the study as: baseline albumin
excretion in morning urine; albumin excretion after ingestion of
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beef; and albumin excretion during physical exercise. Significance
was determined at P < 0.05 by Wilcoxon's test or ANOVA for
repeated measures as indicated (SAS program). Further explor-
atory analyses were performed using Wilcoxon's test. Such explor-
atoly analyses were accepted as significant after Bonferroni
Fig. 2. Time course of albumin excretion rate
(AER) after protein meal ingestion in offspring of
control parents and diabetic parents without and
with diabetic nephropathy (DN). Note the 5.7-
fold increase in offspring of DN (P < 0.005 vs.
controls) and 5.5-fold in the offspring of no DN
(P < 0.05 vs. controls). Symbols are: (•)
controls; (0) offspring no DN; (+) offspring
DN; *P < 0.05, < 0.01, < 0.005;
< 0.001 vs. offspring of diabetic patients.
##P < 0.01. vs. control offspring.
correction. Data are given as x SD (if normally distributed) or
median and range (if not normally distributed).
Results
Night time urinary albumin excretion in offspring of diabetic
parents with or without nephropathy
As shown in Figure 1, significantly higher albumin excretion
rates (AER), although not beyond the normal range (< 20
.tg/min) [15], were noted in offspring of diabetic parents with
nephropathy. Alpha-1-microglobulin levels were below the upper
95th percentile of normal values, that is, < 110 mg/24 hr in all
patients. For albumin and alpha-1-microglobulin, the CVs of
replicate measurements were < 5% and 7%, respectively.
Following a water load (10 mi/kg) AER increased to a similar
proportion in controls (from 4.4 jxg/min, range 0.16—18.5 to 18.4;
2.6—108, that is, 4.8-fold), in offspring of nephropathic diabetic
parents (from 6.8; 1.04—15.5 to 46.6; 3.2—502, that is, 6.4-fold) and
non-nephropathic diabetic parents (4.8; 0.36—17.5 to 24.8; 1.7—
88.7, that is, 3-fold). There was no significant difference in the
proportional increase between the groups.
Urinary albumin excretion rate after protein meal ingestion
As shown in Figure 2, AER increased significantly in all three
groups following ingestion of 300 g cooked beef. The proportional
increase at one hour was significantly higher in offspring of
diabetic parents irrespective of nephropathy when compared with
offspring of non-diabetic parents. The relative changes and result
of statistical analysis were similar, when albumin/creatinine ratios
were used instead of albumin excretion rates.
AER was still higher three hours after ingestion, but returned
to baseline after 21 hours.
Albumin excretion after treadmill exercise
As shown in Figures 3 and 4, AER was significantly higher in
offspring of nephropathic diabetic parents compared to offspring
of non-nephropathic parents or controls. The proportional in-
crease of albumin/creatinine ratio (mg/mmol) was significantly
higher in offspring of nephropathic diabetic parents (median
16-fold; range 1.2 to 236; P < 0.01 vs. controls) than in offspring
of non-nephropathic diabetic parents (median 6.3-fold; 1.5 to 231)
or offspring of non-diabetic parents (median 4.8; 1.2 to 99).
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Fig. 3. Albumin excretion rate (AER) after submaximal treadmill exercise in
offspring of control parents and diabetic parents without and with diabetic
nephropathy (DN). Significant difference between offspring of parents with





Casual BP 24 hr BP Daytime BP Sleeping time BP
Systolic Diastolic Systolic Diastolic Systolic Diastolic Systolic Diastolic
Offspring of control parents 112 10.3 72 8.5 114 8.5 71.6 6.4 117 9.3 74 6.5 106 9.1 66 7.9
(N=30)
Offspring of diabetic parents 114 10.3 73 8.5 117 12.9 74 8.6 120 13.2 77 8.4 107 12.8 69 10.5
without nephropathy (N = 30)
with nephropathy (N = 26) 121 16.7w' 76 8.7 125 169ah 76 9.2 127 16.9°' 78 8.9 115 18.1 69 10.3
a Difference vs. offspring of controls + offspring of non-nephropathic parents, P < 0.01hc Difference vs. offspring of controls, b P < 0.05, C P < 0.01
Blood pressure
Sytolic, but not diastolic, blood pressures tended to be higher in
the offspring of diabetic parents with nephropathy than in the
offspring of diabetic parents without diabetic nephropathy (Table
2, Fig. 5). The differences in systolic blood pressures were
significant when systolic BP values were compared between
offspring of diabetic parents with nephropathy and controls, or
controls combined with offspring of diabetic parents without
diabetic nephropathy. It is of note that the difference in systolic
BP tended to be higher for 24 hour BP and sleeping time BP than
for casual BP. No correlation was found between any of the blood
pressure indices on the one hand and night time or postexercise
AER on the other hand.
Discussion
The present data clearly document increased urinary albumin
excretion rates under baseline conditions as well as after physical
exercise in phenotypically normal, that is, normotensive, non-
smoking, normoglycemic offspring of parents with type II diabetes
and nephropathy compared to offspring of parents with type II
diabetes and no nephropathy. The finding implies that subtle
abnormalities of transglomerular albumin traffic are present in
offspring of nephropathic diabetic patients even prior to the onset
of diabetes mellitus and overt hypertension. Our results do not
yield information whether the increased albumin excretion rate is
related to functional or to structural changes, such as higher
pressure or abnormal characteristics of the glomerular filter. As to
the type of proteinuria, the higher urinary excretion of albumin in
the presence of normal excretion of alpha-1-microglobulin points
to a glomerular rather than a tubular problem.
When evaluated in different fashions, blood pressures were
higher in offspring of diabetic parents with nephropathy, although
all values remained within the normotensive range. The elevation
of values concerned both casual blood pressure and even more
markedly circadian blood pressure. This observation is not ex-
plained by trivial factors such as higher BMI, higher urinary
sodium excretion or confounders such as use of hormonal contra-
ception. Whether increased albumin excretion and higher blood
pressures are causally related is unknown. In particular, higher
postexercise albuminuria may have resulted from higher blood
pressure during exercise (which was not measured). At any rate,
no correlation was noted between the various parameters of blood
pressure and urinary albumin excretion, but the power of the
study was insufficient to be too certain about this point. Recent
observations of reduced nailfold capillary density in the offspring
of hypertensive parents and higher nailfold capillary pressure in
prediabetic individuals 16] provide interesting conceptual links
between systemic and capillary pressures, but we admit that this is
purely speculative.
In a study of this nature, several potential artifacts must be
considered. We made efforts to ensure that the cohort was a
non-biased sample of the local population of type II diabetic
patients. Type II diabetes is certainly heterogenous. We adopted
the categorization according to the National Diabetes Data
Group 9], and a particular effort was made to exclude MODY
and mitochondrial diabetes. A problem arises because the fre-
quency of manifest diabetic nephropathy in the parent generation
must increase with duration of diabetes. As a sensible cut-off we
used known duration of diabetes of ten years. We acknowledge,
however, that this may have led to misclassification of some
parents who may later develop nephropathy. If this is so, this
would tend to obliterate any potential difference between the




Fig. 4. Time course of albuminicreatinine ratio
5 after submaximal treadmill exercise. Note 16-fold
increase in offspring of DN (P < 0.01 vs.
controls) and 6.3-fold increase in offspring of
0 no DN (not significant vs. controls). Symbols
are: (S) controls; (0) offspring no DN; (+)
offspring DN; < 0.05, < 0.01, ***p <
0.005; **** < 0.001 vs. offspring of diabetic
patients. ##P < 0.01. vs. control offspring.
Table 2. Casual and ambulatory blood pressure (mm Hg) in offspring according to presence of diabetes and diabetic nephropathy of parents
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between blood pressure and the albumin excretion rate would
argue against, but does not fully exclude, the notion that higher
AER in offspring of diabetic parents with diabetic nephropathy is
merely a reflection of their higher blood pressures.
We wish to emphasize that physical exercise caused a dispro-
: portionately greater increase of urinary albumin excretion rate in
offspring of parents with type II diabetes and nephropathy com-
pared to offspring of diabetic parents without nephropathy. This is
reminiscent of the dramatic increase of albuminuria by exercise in
patients with type I diabetes and incipient nephropathy [17] and
: X would be consistent with abnormal regulation of systemic and/orI -- I intrarenal hemodynamics. Whether postexercise albuminuria is
predictive of later diabetic nephropathy is unknown.
• The group of Campese [18] showed that individuals with
salt-sensitive blood pressure tend to have higher albumin excre-
:: tion rates than non-salt-sensitive individuals. We do not have data
on salt sensitivity in the present cohort. This possibility requires
further study, since in type I diabetes salt sensitivity of blood
• pressure was noted even in normotensive normoalbuminuric
individuals [19].
Increased albumin excretion is associated with several facets of
the "metabolic syndrome" [20, 21]. We emphasize that the
offspring were all non-obese with normal glucose tolerance and
normal lipid levels. Nevertheless Table 1 documents that BMI,
total cholesterol and total triglyceride concentrations tended to be
somewhat higher in offspring of diabetic parents, but irrespective
of the presence of diabetic nephropathy in the parent generation.
Grünfeld et a! [22] noted higher urinary albumin excretion in
offspring of patients with essential hypertension, compared to
offspring of normotensive parents, particularly after ingestion of a
water and protein load. An acute increase of albumin excretion
after a protein meal was also noted in the present study, but this
was seen in all offspring of type II diabetic parents irrespective of
nephropathy.
The present study thus confirms and extends the observation of
Gruden et al [8], who noted higher albumin concentration in
overnight urine in offspring of type II diabetic parents with
albuminuria. The present study documents abnormal albumin
excretion during stimulatory maneuvers and shows that this is
associated with higher ambulatory blood pressure.
In this population we found a relationship between albuminuria
and genotypes of the ACE gene, that is, 45% of subjects with D/D
genotype versus 15% of subjects with lID or I/I genotype were
above the 95th percentile of morning urine albumin of controls,
that is, 13 jtg/min. This preliminary observation is remarkably in
line with recent observations on a relationship between ACE
polymorphism and microalbuminuria in essential hypertension
[23] and renal prognosis in kidney disease [24—29].
It has been postulated that an abnormality of Na, Li counter-
transport is related to hypertension and the renal risk in diabetes
[30, 31] and this line of evidence has received a more molecular
basis by the recent demonstration of enhanced G protein activa-
tion of Ca2 mobilization and Na/proton countertransport in
patients with type I diabetes and nephropathy [32].
It has repeatedly been postulated that separate genes code for
diabetes per se and for diabetic nephropathy [1, 4, 33]. The results
of the present study would be consistent with such an hypothesis.
The idea that separate genes code for, and predispose to, renal
damage finds some support in recent experimental studies that
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Fig. 5. Ambulatoiy 24 hours systolic blood pressure in offspring of control
parents and diabetic parents without and with diabetic nephropathy (DN).
Significant difference between offspring of parents with DN and controls
(xP <0.01).
groups of offspring and would have underestimated the genetic
risk of nephropathy. We also excluded all offspring who had
manifest hypertension or glucose intolerance and who were
smokers or used hormonal contraception. Exclusion of such high
risk offspring may have led to underestimation of the difference
between groups. Indeed, hypertensive offspring of diabetic par-
ents with nephropathy who had been excluded from the present
study had higher values of AER (8.2 tg/min, range 5.3 to 18.4)
compared to hypertensive offspring of non-nephropathic diabetic
parents (6.1 jtglmin; 4.3 to 10.1).
A family study does not allow one to distinguish between
genetic factors and shared environment. Although we cannot fully
exclude the latter possibility, the data would also be consistent
with the operation of genetic factors. Measurements of dietary
factors that are known to affect albumin excretion rate, particu-
larly protein intake (estimated from urea excretion) and salt
intake (estimated from sodium excretion) did not show differ-
ences between the groups. Furthermore, the lack of correlation
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determination for indicators of progressive renal dysfunction in
one model of glomeruloscierosis, that is, the fawn hooded rat [31.
We admit that this interpretation of our preliminary results is
speculative and that further studies are required.
The present data are in agreement with the notion that intitial
changes in renal function are seen very early in the life of subjects
predisposed to diabetes. Such changes may potentially determine
the risk to ultimately develop diabetic nephropathy, but this
remains currently unproven. Whether such early renal abnormal-
ities have a structural basis, as postulated by one recent hypothesis
[35, 36], or are of functional nature, such as higher blood pressure,
abnormal intrarenal hemodynamics or abnormal glomerular
permselectivity, requires further study.
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